2 years ago
ABBV
AnalystsGary NachmanGary Nachman's Stock Forecasts
AnalystsGary Nachman
Analyst Ranking
Bottom 11%
#4110 out of 4565 analysts
Average Return
-3.18%
Win Rate
47%27 out of 58
Risk vs Reward
Poor
Good
Gary Nachman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sage Therapeutics IncSAGE | +205.03% | $29.03 | $88.55 | 2020-04-08 - 2021-01-22 | Buy |
Sage Therapeutics IncSAGE | +128.79% | $64.85 | $148.37 | 2017-09-13 - 2018-09-14 | Buy |
Rigel Pharmaceuticals IncRIGL | +125.63% | $0.72 | $1.62 | 2022-06-08 - 2023-06-08 | Buy |
Veru IncVERU | +72.86% | $0.70 | $1.21 | 2024-03-27 - 2024-04-25 | Buy |
Horizon Therapeutics Public Ltd CoHZNP | +68.51% | $67.00 | $112.90 | 2022-08-03 - 2022-12-13 | Buy |
Gary Nachman Analyst Color
Get additional color on Gary Nachman's coverage of popular stocks
Gary Nachman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | 4 | Strong Buy | $30.00 | +114.90% | Initiates Coverage On | a month ago |
Aquestive Therapeutics IncAQST | 1 | Buy | $7.00 | +78.12% | Initiates Coverage On | a month ago |
Veru IncVERU | 1 | Buy | $3.00 | +147.93% | Initiates Coverage On | a month ago |
Abbvie IncABBV | 12 | Buy | $189.00 | +12.98% | Maintains | 3 months ago |
Pacira Biosciences IncPCRX | 9 | Buy | $42.00 | +64.71% | Initiates Coverage On | 4 months ago |
Alnylam Pharmaceuticals IncALNY | 5 | Buy | $208.00 | +44.74% | Initiates Coverage On | 7 months ago |
Schrodinger IncSDGR | 3 | Buy | $67.00 | +187.06% | Maintains | 9 months ago |
Amneal Pharmaceuticals IncAMRX | 2 | Hold | $4.00 | N/A | Maintains | a year ago |
Phathom Pharmaceuticals IncPHAT | 4 | Buy | $30.00 | N/A | Maintains | a year ago |
Ionis Pharmaceuticals IncIONS | 2 | Buy | $67.00 | N/A | Maintains | a year ago |
Abcellera Biologics IncABCL | 1 | Buy | $32.00 | N/A | Maintains | a year ago |
Viatris IncVTRS | 2 | Hold | $14.00 | N/A | Downgrades | a year ago |
Horizon Therapeutics Public Ltd CoHZNP | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Optinose IncOPTN | 3 | Buy | $5.00 | N/A | Maintains | a year ago |
9 Meters Biopharma IncNMTRQ | 3 | Buy | $35.00 | N/A | Maintains | a year ago |
Sage Therapeutics IncSAGE | 6 | Hold | $40.00 | N/A | Maintains | a year ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | $10.00 | N/A | Maintains | a year ago |
Rigel Pharmaceuticals IncRIGL | 2 | Buy | $3.00 | N/A | Maintains | a year ago |
Aptinyx IncAPTX | 1 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Polypid LtdPYPD | 2 | Buy | $750.00 | N/A | Maintains | 2 years ago |
Bausch Health Companies IncBHC | 2 | Hold | $8.00 | N/A | Maintains | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 6 | Buy | $188.00 | N/A | Maintains | 2 years ago |
Endo International PLCENDPQ | 4 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Flexion Therapeutics IncFLXN | 4 | Hold | $12.00 | N/A | Downgrades | 3 years ago |
Lannett Co IncLCINQ | 3 | Hold | $32.00 | N/A | Maintains | 6 years ago |
Scpharmaceuticals IncSCPH | 2 | Buy | $14.00 | N/A | Maintains | 6 years ago |
Impax Laboratories IncIPXL | 1 | Hold | $20.00 | N/A | Maintains | 6 years ago |
Amphastar Pharmaceuticals IncAMPH | 2 | Hold | $19.00 | N/A | Maintains | 6 years ago |
Neos Therapeutics IncNEOS | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.